Remedor Biomed Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Remedor Biomed General Information

Description

Provider of a biomedical technology platform based on the combination of two naturally-occurring glycoproteints: erythropoietin (EPO) and fibronectin (FN). The company develops a formulation, based on erythropoietin and fibronectin, for therapeutical use in tissue regeneration in the processes of wound healing and bone repair.

Contact Information

Website
remedor.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Social/Platform Software
Primary Office
  • Ha-Avoda Street 12
  • Nazareth Iliit
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Remedor Biomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Remedor Biomed’s complete valuation and funding history, request access »

Remedor Biomed Executive Team (2)

Name Title Board Seat Contact Info
Saher Remedor Ph.D Founder, Chief Technology Officer & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Remedor Biomed Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Next Generation Technology Venture Capital Minority 000 0000 000000 0
To view Remedor Biomed’s complete investors history, request access »